石四药集团(02005)：吗啉硝唑获国家药监局批准登记成为在上市制剂使用的原料药

Core Viewpoint - The announcement by the company indicates that its drug, Metronidazole, has been approved by the National Medical Products Administration of China for use as an active pharmaceutical ingredient in marketed formulations [1] Group 1: Company Information - The company, Shijiazhuang Fourth Pharmaceutical Group, has received regulatory approval for Metronidazole, a nitroimidazole antibiotic [1] - Metronidazole is primarily used for the treatment of anaerobic bacterial infections, specifically appendicitis and pelvic inflammatory disease [1]